Sensa -

In the 1980s, an inner-city physician and neurologist named Dr. Alan Hirsch noticed something curious while treating patients who had lost their sense of smell: they almost always gained weight. This observation sparked a theory that would eventually lead to the creation of , one of the most famous weight-loss crazes of the early 2010s. The Science of "Sensory-Specific Satiety"

Sensa was marketed as a "sprinkle-on" diet. There were no pills, no calorie counting, and no banned foods. Users simply carried two shakers—one for savory foods (like pizza or meat) and one for sweet foods (like fruit or ice cream)—and "seasoned" everything they ate. The Meteoric Rise In the 1980s, an inner-city physician and neurologist

By 2012, Sensa was a juggernaut. Backed by aggressive infomercials and celebrity endorsements (including Millionaire Matchmaker Patti Stanger), the company reported over $160 million in annual sales. It appealed to the ultimate human desire: losing weight without changing a single habit. It was the "magic dust" the world had been waiting for. The FTC and the Fall The Science of "Sensory-Specific Satiety" Sensa was marketed

Hirsch’s idea was based on "sensory-specific satiety." He believed that the brain receives signals from the nose and tongue to tell the body it’s full. By enhancing the smell and taste of food using "tastants"—highly concentrated aromatic crystals—he claimed he could trick the brain into feeling satisfied much faster. The Meteoric Rise By 2012, Sensa was a juggernaut

Sensa was ordered to pay a —the largest of its kind at the time—which was used to provide refunds to consumers. Shortly after, the company filed for bankruptcy and disappeared from shelves. The Legacy

However, the scientific community remained skeptical. While Hirsch cited internal studies claiming users lost an average of 30 pounds in six months, independent researchers couldn't replicate the results.

In 2014, the stepped in. They charged Sensa with making "unfounded weight-loss claims" and using misleading clinical studies. The FTC pointed out that the "tastants" were essentially maltodextrin (a food additive), silica, and various flavorings—hardly a pharmacological breakthrough.